Why the study?
Does extended prophylaxis with fondaparinux reduce VTE in patients undergoing hip fracture surgery?
Population
656 patients undergoing hip fracture surgery who had received initial fondaparinux prophylaxis for 6 to 8…
Comparison
Fondaparinux 2.5 mg once-daily subcutaneous… vs Placebo once-daily subcutaneous injection for 19…
Design
RCT, randomly assigned, double-blind
Follow-up
19 to 23 days
Authors
Loading...
Supports extended fondaparinux prophylaxis after hip fracture surgery; confirms large VTE reduction in this high-risk population.
Does extended prophylaxis with fondaparinux reduce VTE in patients undergoing hip fracture surgery?
Extended prophylaxis with fondaparinux for 3 weeks after hip fracture surgery significantly reduces the risk of VTE by 96%.
Bengt I. Eriksson (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: